Kandhi S et al. |
EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice. |
2016 |
Am. J. Hypertens. |
pmid:26304959
|
Diani-Moore S et al. |
Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA. |
2014 |
Drug Metab. Dispos. |
pmid:24311719
|
Frömel T et al. |
Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques. |
2013 |
Basic Res. Cardiol. |
pmid:23224081
|
Cracowski JL et al. |
Involvement of cytochrome epoxygenase metabolites in cutaneous postocclusive hyperemia in humans. |
2013 |
J. Appl. Physiol. |
pmid:23172029
|
Gamliel-Lazarovich A et al. |
Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid. |
2012 |
Atherosclerosis |
pmid:22365750
|
Herse F et al. |
Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia. |
2012 |
Circulation |
pmid:23155181
|
Sisignano M et al. |
5,6-EET is released upon neuronal activity and induces mechanical pain hypersensitivity via TRPA1 on central afferent terminals. |
2012 |
J. Neurosci. |
pmid:22553041
|
Snider NT et al. |
A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist. |
2009 |
Mol. Pharmacol. |
pmid:19171674
|
Loot AE et al. |
Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation. |
2008 |
Cardiovasc. Res. |
pmid:18682435
|
Li Y et al. |
Arachidonic acid metabolites inhibit the stimulatory effect of angiotensin II in renal proximal tubules. |
2008 |
Hypertens. Res. |
pmid:19139605
|